Please login to the form below

Not currently logged in


This page shows the latest protein news and features for those working in and with pharma, biotech and healthcare.

Celgene bulks up pipeline again with $2.1bn Prothena deal

Celgene bulks up pipeline again with $2.1bn Prothena deal

Prothena has a legacy of innovation in neuroscience and a team with a deep understanding of biological approaches that target protein misfolding disorders, ”said Hargreaves of the new deal. ... Our collaboration leverages each company’s core

Latest news

More from news
Approximately 3 fully matching, plus 634 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Collaboration, option. 879. Arvinas/Pfizer. Drug candidates using PROTAC (PROteolysis TArgeting Chimeras) Platform to create small molecules aimed at degrading disease-causing cellular proteins.

  • Pharma’s coral reef Pharma’s coral reef

    Here, the Darwinian parallels helps us still further. Just as proteins are the workhorses within organisms, capabilities are the things that do the work within organisations. ... And, just as proteins are expressed by complex combinations of genes,

  • Digital disruption Digital disruption

    On computer screens, AZ scientists can then ‘drag and drop’the essential ingredients of the biological processes they are interested in - cells, genes and proteins.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Ogeda is developing drugs targeting G-protein coupled receptors. The lead product is a NK3 receptor antagonist (fezolinetant) for treatment of menopause-related vasomotor symptoms (hot flashes).

  • Reactivating drug research programmes Reactivating drug research programmes

    Now, growing use of genetic-profiling technologies is enabling them to look for ‘biomarkers’, such as protein indicators or genetic mutations, which could help to target both new and existing treatments

More from intelligence
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest from PMHub

  • Introduction to the manufacturing of biologics

    However, the broad definition of a biologic is they are created by either a microorganism or a mammalian cell, and are large, complex molecules; the majority of which are proteins

  • Alzheimer's and Brain Awareness Month

    The symptoms of AD are believed to be caused by an atypical build-up of proteins within the brain in the forms of ‘ plaques’ and ‘ tangles’, which impairs connections between neurons ... It is particularly challenging to tackle AD, as is it still

  • Forecasting in Forgotten Markets

    From a scientific perspective, the jury is still out on the root cause of these conditions and whether the current hypothesis around the involvement of Amyloid and Tau proteins in different

  • Flarebio Biotech LLC

    Our main business includes recombinant proteins and antibodies (CusAb), ELISA kits (CUSABIO), raw materials for diagnostic reagents (CUSAg), food safety testing products (WHISERKON).

  • Creating effective digital sales aids for pharma and the nutraceutical industry – Souvenaid case study

    The relationship with Nutricia began with PharmiWeb Solutions in May 2012 – this started with a digital selling aid for Fortisip Compact Protein, a meal supplement drink.Following the successful launch of

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...